Pricing Log in Create free account

Promis Neurosciences (PMN) vs Telomir Pharmaceuticals, Inc. (TELO)

Promis Neurosciences and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Promis Neurosciences and Telomir Pharmaceuticals, Inc. are of similar size ($78.0M and $77.3M). Across the 9 metrics below, Promis Neurosciences leads on 5 and Telomir Pharmaceuticals, Inc. on 4.

Valuation

Metric PMN TELO Biotechnology median
P/E n/m n/m 8.50
P/S 33,868.44 n/m 9.71
P/B 1.51 12.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 11,382.03 n/m 9.21
Earnings yield (155.70%) (85.85%) (33.15%)
Free cash flow yield (56.51%) (7.62%) (25.50%)

Profitability

Metric PMN TELO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (172.30%) (1,885.50%) (56.36%)
Return on assets (127.57%) (1,678.31%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PMN TELO Biotechnology median
Revenue growth (TTM) 450.00% — 6.02%
EPS growth (last fiscal year) (922.18%) 41.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PMN TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 7.85 16.14 4.72
Net debt to EBITDA 0.15 0.69 0.96

Dividend

Metric PMN TELO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PMN TELO Biotechnology median
Market cap 78.02m 77.30m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack